Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management.
Frontiers in Psychiatry 2022 Ryan Yip, Jennifer Swainson, Atul Khullar et al. 13 citations
Ketamine is a versatile medication with an emerging role for the treatment of numerous psychiatric conditions, including treatment resistant depression. Current psychiatry guidelines for its intravenous administration to treat depression recommend regular blood pressure monitoring and an aggressive approach to potential transient hypertensive episodes induced by ketamine infusions. While this...
DOI: 10.3389/fpsyt.2022.1017504 (opens in new tab)
Full text (opens in new tab)
Hypertension
Hypertensive emergency
Ketamine infusion
Treatment resistant depression